Back to search

Czechia· CZ-0173661

OLMESARTAN/AMLODIPIN ZENTIVA

A olmesartan medoxomil und amlodipin product containing olmesartan medoxomil + amlodipine besilate, registered in Czechia by Zentiva, k.s., Praha. The same ATC class is registered in 8 of our 19 countries.

ATC C09DB02

Checked against SÚKL (Czech Republic) on

Informational only — not a medical device.

SOURCE REGISTER · CZSÚKL (Czech Republic)normalisedOLMESARTAN/AMLODIPIN ZENTIVAATCC09DB02REGISTER NO.CZ-0173661PACKS LISTED0CHECKEDSeptember 28, 2026

Where it is registered

Olmesartan medoxomil und amlodipin is registered in 8 of 19 countries.

Countries holding a registration under ATC C09DB02 (olmesartan medoxomil und amlodipin), each read from that country’s own register.

  • This record: Czechia, from SÚKL (Czech Republic)
  • 6 of them publish a price we can compare per daily dose

Olmesartan medoxomil und amlodipin · ATC C09DB02

8 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

SÚKL (Czech Republic)
Active substance
OLMESARTAN MEDOXOMIL + AMLODIPINE BESILATE
Manufacturer
Zentiva, k.s., Praha
Country
Czechia (CZ)
ATC code
C09DB02
ATC class
Olmesartan medoxomil und Amlodipin
Reimbursed
Not published by this register
Source register
SÚKL (Czech Republic)
Last checked
September 28, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

81 interactions on record for olmesartan medoxomil und amlodipin.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Olmesartan medoxomil und amlodipin · interactions on record

81 records

81 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Olmesartan medoxomil und amlodipin in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All olmesartan medoxomil und amlodipin products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Amelior, Olmesartan/Amlodipin 1a Pharma
  • Belgium · Forzaten, Forzaten®
  • Bulgaria · Amlodipine Besilate / Olmesartan Medoxomil Viatris Limited, Амлосарт
  • Cyprus · Alsamod, Comprelan
  • Germany · Olmeamlo, Olmeamlodipin Puren
  • Estonia · Olmesartan Medoxomil/Amlodipine Accord, Olmesartan Medoxomil/Amlodipine Zentiva
  • Spain · Albis, Balzak
  • Finland · Olmesartan Medoxomil/Amlodipine Krka
  • France · Axeler, Sevikar
  • United Kingdom (Northern Ireland) · Olmesartan Medoxomil And Amlodipine Clydesdale Pharma, Olmesartan Medoxomil/Amlodipine Accord Healthcare
  • Greece · Comprelan, Olmedipin
  • Croatia · Olmita
  • Hungary · Duactan, Olmiza
  • Ireland · Konverge, Olmesartan /Amlodipine Mylan
  • Italy · Bivis, Giant
  • Lithuania · Olmesartan Medoxomil /Amlodipine Sandoz, Olmesartan Medoxomil/Amlodipine Accord
  • Luxembourg · Forzaten, Olmesartan/Amlodipine Eg
  • Latvia · Olmesartan Medoxomil/ Amlodipine Zentiva, Olssa
  • Malta · Konverge, Olmesartan Medoxomil/Amlodipine Ascend
  • Netherlands · Amlodipine Besylate/ Olmesartan Medoxomil Aurobindo, Amlodipine Besylate/Olmesartan Medoxomil Aurobindo
  • Poland · Elestar, Olmita
  • Portugal · Amlodipina + Olmesartan Medoxomilo Alter, Amlodipina + Olmesartan Medoxomilo Aurovitas
  • Romania · Almacor Duo, Inovum
  • Slovenia · Olectan, Olmita
  • Slovakia · Folgan

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ec14cde0-2601-4f9c-beae-eb179577b222
GET /v1/drugs/ec14cde0-2601-4f9c-beae-eb179577b222?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "TBL FLM",
  "source": "sukl",
  "strength": "20MG/5MG",
  "pack_size": "56",
  "substance": "OLMESARTAN MEDOXOMIL + AMLODIPINE BESILATE",
  "cz_kod_sukl": "0173661",
  "product_type": "CH",
  "substance_codes": "15600,12990",
  "registration_state": "R",
  "registration_number": "58/815/16-C"
}

See everything about olmesartan medoxomil und amlodipin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.